Project Grant R01AI177445
Award Date
7/17/24
Completion Date
5/31/29
Dollars Obligated
$948K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Aurora, CO 80045, USA
Similar Awards
This federal Project Grant award, with a total funding amount of $794,849, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant supports research to investigate mechanisms of antibiotic resistance and cross-protection in Pseudomonas aeruginosa, a bacterium that causes lung infections in individuals with cystic fibrosis. The key objectives are to: 1) determine how specific genetic...
This $693,422 Project Grant award from the National Institute of General Medical Sciences (CFDA 93.859 Biomedical Research and Research Training program) aims to support a multidisciplinary research effort to gain a fundamental mechanistic understanding of essential membrane transporters. The five-year project, awarded to the University of Colorado-Denver, will pursue three key objectives: 1) understanding substrate selectivity and promiscuity of these transporters, 2) probing the connection...
The National Institute of General Medical Sciences (NIGMS) awarded a $382,616 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to New Mexico State University to elucidate the structure, function, and mechanism of bacterial ATP-binding cassette (ABC) transporters that regulate the essential metal zinc. The 5-year project aims to determine the first high-resolution structures of intact zinc ABC transporter systems from two divergent families, ZnuABC and ZrgABCDE, which are...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $569,210 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Regents of the University of Colorado (CU) to conduct research aimed at understanding and mitigating antimicrobial resistance in gram-negative bacteria. The key objectives are to structurally and functionally characterize three proteins directly responsible for resistance to cationic antimicrobial peptides (CAMPs) and...
This $721,194 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 Allergy and Infectious Diseases Research) supports a research project to investigate the structural and functional roles of key protein complexes involved in the cell division process of Mycobacterium tuberculosis (MTB), the bacterium that causes tuberculosis (TB). The primary objectives are: 1) to characterize the structure and interactions of the FtsQ-FtsZ protein complex, which may...
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded a $637,275 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the Texas A&M Engineering Experiment Station (Tees) to conduct research on rapid stress response mechanisms in bacterial pathogens. The research will investigate how Gram-negative bacterial cells can rapidly adapt their outer membrane to develop tolerance against chemical stressors, such as antibiotics, by...
This federal Project Grant award, totaling $1,148,562.00, was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The award aims to investigate two families of bacterial transmembrane transporters - ClCF F-/H+ antiporters and fluoride ion channels, as well as P1B-type ATPases that transport Cu+, Cu2+, and Zn2+ across cellular membranes. The research will combine advanced computational techniques,...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $811,396 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Oklahoma to characterize the mechanisms and structures of specific mycobacterial membrane protein large (MMPL) transporters. The project aims to define the transport activities of MMPL3, MMPL5, and MMPL7 transporters, reconstitute and characterize their activities in complexes with partner proteins, and...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $1,024,897 over a period of 5 years to support research aimed at understanding the innate immune response to Yersinia bacterial infection. The key focus is on investigating how monocyte-derived TNF and IL-1 signaling regulates the formation and function of pyogranulomas, which are organized immune structures...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $189,150.00 to support research to identify new regulators of outer membrane vesicle (OMV) entry into macrophages. The goal is to bridge a major knowledge gap by characterizing the upstream mechanisms of OMV-macrophage interactions, OMV endocytosis, and translocation of OMV components across the endosomal membrane....